M 7583 companion diagnostic - HTG Molecular Diagnostics/Merck
Latest Information Update: 17 Oct 2016
At a glance
- Originator HTG Molecular Diagnostics; Merck KGaA
- Developer HTG Molecular Diagnostics
- Class Diagnostic agents
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research B cell lymphoma